Annual Cash & Cash Equivalents
$171.99 M
+$76.98 M+81.04%
December 31, 2024
Summary
- As of March 12, 2025, URGN annual cash & cash equivalents is $171.99 million, with the most recent change of +$76.98 million (+81.04%) on December 31, 2024.
- During the last 3 years, URGN annual cash & cash equivalents has risen by +$127.63 million (+287.71%).
- URGN annual cash & cash equivalents is now at all-time high.
Performance
URGN Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Cash And Cash Equivalents
$171.99 M
+$47.07 M+37.68%
December 1, 2024
Summary
- As of March 12, 2025, URGN quarterly cash and cash equivalents is $171.99 million, with the most recent change of +$47.07 million (+37.68%) on December 1, 2024.
- Over the past year, URGN quarterly cash and cash equivalents has increased by +$47.07 million (+37.68%).
- URGN quarterly cash and cash equivalents is now -30.28% below its all-time high of $246.69 million, reached on March 31, 2019.
Performance
URGN Quarterly Cash And Cash Equivalents Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash And Cash Equivalents Formula
Cash & Cash Equivalents = Cash + Short-Term Investments
URGN Cash And Cash Equivalents Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +81.0% | +37.7% |
| 3 y3 years | +287.7% | +287.7% |
| 5 y5 years | +246.1% | +246.1% |
URGN Cash And Cash Equivalents Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | at high | +287.7% | -21.8% | +754.5% |
| 5 y | 5-year | at high | +287.7% | -21.8% | +754.5% |
| alltime | all time | at high | +856.8% | -30.3% | +754.5% |
UroGen Pharma Cash And Cash Equivalents History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | $171.99 M(+81.0%) | - |
| Dec 2024 | - | $171.99 M(+37.7%) |
| Sep 2024 | - | $124.92 M(-43.2%) |
| Jun 2024 | - | $219.97 M(+67.4%) |
| Mar 2024 | - | $131.44 M(+38.4%) |
| Dec 2023 | $95.00 M(+71.5%) | $95.00 M(-20.4%) |
| Sep 2023 | - | $119.31 M(+492.8%) |
| Jun 2023 | - | $20.13 M(-44.9%) |
| Mar 2023 | - | $36.54 M(-34.1%) |
| Dec 2022 | $55.41 M(+24.9%) | $55.41 M(+93.2%) |
| Sep 2022 | - | $28.69 M(-64.4%) |
| Jun 2022 | - | $80.69 M(-23.4%) |
| Mar 2022 | - | $105.38 M(+137.6%) |
| Dec 2021 | $44.36 M(-16.1%) | $44.36 M(-19.8%) |
| Sep 2021 | - | $55.34 M(-12.6%) |
| Jun 2021 | - | $63.32 M(+56.4%) |
| Mar 2021 | - | $40.49 M(-23.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2020 | $52.86 M(+6.4%) | $52.86 M(+115.2%) |
| Sep 2020 | - | $24.57 M(-32.4%) |
| Jun 2020 | - | $36.35 M(+37.3%) |
| Mar 2020 | - | $26.47 M(-46.7%) |
| Dec 2019 | $49.69 M(-51.0%) | $49.69 M(-24.9%) |
| Sep 2019 | - | $66.15 M(-26.8%) |
| Jun 2019 | - | $90.42 M(-63.3%) |
| Mar 2019 | - | $246.69 M(+143.5%) |
| Dec 2018 | $101.32 M(+173.8%) | $101.32 M(-7.5%) |
| Sep 2018 | - | $109.48 M(-8.1%) |
| Jun 2018 | - | $119.11 M(-6.6%) |
| Mar 2018 | - | $127.46 M(+244.5%) |
| Dec 2017 | $37.00 M(+73.2%) | $37.00 M(-53.3%) |
| Sep 2017 | - | $79.17 M(+2.7%) |
| Jun 2017 | - | $77.09 M(+260.9%) |
| Dec 2016 | $21.36 M(+18.8%) | $21.36 M |
| Dec 2015 | $17.98 M | - |
FAQ
- What is UroGen Pharma annual cash & cash equivalents?
- What is the all time high annual cash & cash equivalents for UroGen Pharma?
- What is UroGen Pharma annual cash & cash equivalents year-on-year change?
- What is UroGen Pharma quarterly cash and cash equivalents?
- What is the all time high quarterly cash and cash equivalents for UroGen Pharma?
- What is UroGen Pharma quarterly cash and cash equivalents year-on-year change?
What is UroGen Pharma annual cash & cash equivalents?
The current annual cash & cash equivalents of URGN is $171.99 M
What is the all time high annual cash & cash equivalents for UroGen Pharma?
UroGen Pharma all-time high annual cash & cash equivalents is $171.99 M
What is UroGen Pharma annual cash & cash equivalents year-on-year change?
Over the past year, URGN annual cash & cash equivalents has changed by +$76.98 M (+81.04%)
What is UroGen Pharma quarterly cash and cash equivalents?
The current quarterly cash and cash equivalents of URGN is $171.99 M
What is the all time high quarterly cash and cash equivalents for UroGen Pharma?
UroGen Pharma all-time high quarterly cash and cash equivalents is $246.69 M
What is UroGen Pharma quarterly cash and cash equivalents year-on-year change?
Over the past year, URGN quarterly cash and cash equivalents has changed by +$47.07 M (+37.68%)